135 related articles for article (PubMed ID: 9876211)
21. Structure-antileukemic activity relationship study of B- and D-ring modified and nonmodified steroidal esters of 4-methyl-3-N,N-bis(2-chloroethyl)amino benzoic acid: a comparative study.
Fousteris MA; Koutsourea AI; Arsenou ES; Papageorgiou A; Mourelatos D; Nikolaropoulos SS
Anticancer Drugs; 2007 Oct; 18(9):997-1004. PubMed ID: 17704649
[TBL] [Abstract][Full Text] [Related]
22. Structure--anticancer and structure--genetic activity relationships of homo-aza-steroidal esters of N,N-bis(2-chloroethyl)aminocinnamic acid isomers.
Catsoulacos P; Camoutsis C; Papageorgiou A; Margariti E; Psaraki K; Demopoulos N
J Pharm Sci; 1993 Feb; 82(2):204-8. PubMed ID: 8445536
[TBL] [Abstract][Full Text] [Related]
23. Potential antitumor agent: steroidal bilactam ester of p-N, N-bis (2-chloroethyl) aminophenylacetic acid.
Catsoulacos P; Camoutsis C; Papageorgiou A
Anticancer Res; 1995; 15(3):827-30. PubMed ID: 7645966
[TBL] [Abstract][Full Text] [Related]
24. A comparative study on cytogenetic and antineoplastic effects induced by two modified steroidal alkylating agents.
Papageorgiou A; Tsavdaridis D; Geromichalos GD; Camoutsis C; Karaberis E; Mourelatos D; Chrysogelou E; Houvartas S; Kotsis A
Cancer Detect Prev; 2001; 25(4):369-74. PubMed ID: 11531014
[TBL] [Abstract][Full Text] [Related]
25. Antitumor activity of homo-aza-steroidal esters of p-N, N-bis(2-chloroethyl)aminophenoxyacetic acid.
Catsoulacos P; Catsoulacos D
Anticancer Res; 1993; 13(4):1203-8. PubMed ID: 8352545
[TBL] [Abstract][Full Text] [Related]
26. Induction of cytogenetic damage by modified steroidal derivatives of p-bis(2-chloroethyl)aminophenylacetic acid in human lymphocytes.
Mourelatos D; Petrou C; Boutis L; Papageorgiou A; Catsoulacos P; Dozi-Vassiliades J
Mutat Res; 1987 Mar; 190(3):205-10. PubMed ID: 3821781
[TBL] [Abstract][Full Text] [Related]
27. Comparison of new nitrosoureas esters with modified steroidal nucleus for cytogenetic and antineoplastic activity.
Hussein A; Mioglou-Kalouptsi E; Papageorgiou A; Karapidaki I; Iakovidou-Kritsi Z; Lialiaris T; Xrysogelou E; Camoutsis C; Mourelatos D
In Vivo; 2007; 21(2):389-95. PubMed ID: 17436593
[TBL] [Abstract][Full Text] [Related]
28. Potentiation by caffeine of cytogenetic damage induced by steroidal derivatives in human lymphocytes in vitro.
Mourelatos C; Nikolaropoulos S; Fousteris M; Pairas G; Argyraki M; Lykidis D; Fidani S; Mourelatos D; Lialiaris T
Mutat Res Genet Toxicol Environ Mutagen; 2014 May; 766():42-5. PubMed ID: 24680952
[TBL] [Abstract][Full Text] [Related]
29. Induction of chromosomal aberrations in human lymphocytes by the antitumour alkylating agent homo-aza-steroidal ester of p-bis(2-chloroethyl)aminophenoxy acetic acid, in vitro.
Tselepi MR; Zacharopoulou A; Demopoulos NA; Catsoulacos P
Mutat Res; 1993 Dec; 290(2):211-6. PubMed ID: 7694112
[TBL] [Abstract][Full Text] [Related]
30. A new steroidal alkylating agent with improved activity in advanced murine leukemias.
Catsoulacos P; Politis D; Wampler GL
Cancer Chemother Pharmacol; 1979; 3(1):67-70. PubMed ID: 535128
[TBL] [Abstract][Full Text] [Related]
31. Mutagenicity and clastogenicity of the antineoplastic agents homo-azasteroidal ester of p-bis(2-chloroethyl)aminophenyl acetic acid and chlorambucil.
Athanasiou K; Arzimanoglou II; Arzimanoglou I
Mutat Res; 1986 Nov; 175(3):165-9. PubMed ID: 3534561
[TBL] [Abstract][Full Text] [Related]
32. Steroidal esters of the aromatic nitrogen mustard 2-[4-N,N-bis(2-chloroethyl)amino-phenyl]butanoic acid (2-PHE-BU): synthesis and in-vivo biological evaluation.
Papaconstantinou IC; Fousteris MA; Koutsourea AI; Pairas GN; Papageorgiou AD; Nikolaropoulos SS
Anticancer Drugs; 2013 Jan; 24(1):52-65. PubMed ID: 23187313
[TBL] [Abstract][Full Text] [Related]
33. Effect of an homo-aza-steroidal ester on estrogen receptor.
Leclercq G; Devleeschouwer N; Pairas G; Camoutsis C; Catsoulacos P
Methods Find Exp Clin Pharmacol; 1983; 5(6):365-7. PubMed ID: 6621181
[TBL] [Abstract][Full Text] [Related]
34. 7-Keto hybrid steroidal esters of nitrogen mustard: cytogenetic and antineoplastic effects.
Karayianni V; Papageorgiou A; Mioglou E; Iakovidou Z; Mourelatos D; Fousteris M; Koutsourea A; Arsenou E; Nikolaropoulos S
Anticancer Drugs; 2002 Jul; 13(6):637-43. PubMed ID: 12172510
[TBL] [Abstract][Full Text] [Related]
35. Further studies on the antineoplastic activity of homo-aza-steroidal esters.
Pairas G; Catsoulacos P; Papageorgiou A; Boutis L
Oncology; 1986; 43(6):344-8. PubMed ID: 3808565
[TBL] [Abstract][Full Text] [Related]
36. Comparative study on cytogenetic damage induced by homo-aza-steroidal esters in human lymphocytes.
Mourelatos D; Papageorgiou A; Boutis L; Catsoulacos P
Mutat Res; 1995 Feb; 334(1):19-22. PubMed ID: 7528334
[TBL] [Abstract][Full Text] [Related]
37. Cytogenetic and antineoplastic effects of modified steroidal alkylators.
Karapidaki I; Papageorgiou A; Geromichalos G; Fousteris M; Papaconstadinou I; Pairas G; Koutsourea A; Mourelatos D; Nikolaropoulos S; Lialiaris T
Genet Test Mol Biomarkers; 2010 Feb; 14(1):93-7. PubMed ID: 20025537
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and evaluation of new steroidal lactam conjugates with aniline mustards as potential antileukemic therapeutics.
Trafalis D; Geromichalou E; Dalezis P; Nikoleousakos N; Sarli V
Steroids; 2016 Nov; 115():1-8. PubMed ID: 27473822
[TBL] [Abstract][Full Text] [Related]
39. Antitumor activity of homo-aza-steroidal esters of [p-[bis(2-chloroethyl)amino]phenyl]acetic acid and [p-[bis(2-chloroethyl)amino]phenyl]butyric acid.
Catsoulacos P; Politis D; Wampler GL
Cancer Chemother Pharmacol; 1983; 10(2):129-32. PubMed ID: 6831626
[TBL] [Abstract][Full Text] [Related]
40. Rational design, synthesis, and in vivo evaluation of the antileukemic activity of six new alkylating steroidal esters.
Koutsourea AI; Fousteris MA; Arsenou ES; Papageorgiou A; Pairas GN; Nikolaropoulos SS
Bioorg Med Chem; 2008 May; 16(9):5207-15. PubMed ID: 18353651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]